Latest News and Press Releases
Want to stay updated on the latest news?
-
NEW YORK, July 27, 2016 (GLOBE NEWSWIRE) -- The Board of Directors of Nasdaq, Inc (Nasdaq:NDAQ) has declared a regular quarterly dividend of $0.32 per share on the company's outstanding common...
-
Record quarterly revenue of $303.1 millionGAAP net income of $32.9 million, or $0.23 per diluted shareNon-GAAP net income of $40.3 million, or $0.28 per diluted share BILLERICA, Mass., July 27, 2016...
-
REHOVOT, Israel, July 27, 2016 (GLOBE NEWSWIRE) -- NeuroDerm Ltd. (Nasdaq:NDRM), a clinical stage pharmaceutical company developing drugs for central nervous system (CNS) disorders, today...
-
PHOENIX, July 27, 2016 (GLOBE NEWSWIRE) -- Inventure Foods, Inc. (NASDAQ:SNAK) (“Inventure Foods” or the “Company”), a leading specialty food marketer and manufacturer, today announced that the...
-
Net Sales in the Second Quarter Total $41.0 Million, up 3.6% SequentiallyGross Margin in the Second Quarter Improves to $4.3 million, or 10.6% of SalesCash Flow From Operating Activities in the Second...
-
LAKE SUCCESS, N.Y., July 27, 2016 (GLOBE NEWSWIRE) -- Broadridge Financial Solutions, Inc. (NYSE:BR) is scheduled to release its financial results for the fourth quarter and fiscal year ended June...
-
SAN DIEGO, July 27, 2016 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, today announced that...
-
Clinical Advisory Board of leading orthopedic specialists and experts in rehabilitation met to discuss the design of the Phase III study prior to submission of the protocol to the FDAPluristem has...
-
Flügger A/S, Islevdalvej 151, 2610 Rødovre, 2016-07-27 12:56 CEST (GLOBE NEWSWIRE) -- Til aktionærerne i Flügger A/S 27. juli 2016 Der indkaldes herved til...
-
MEDFORD, N.Y., July 27, 2016 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq:CEMI), a leader in point-of-care (POC) diagnostic tests for infectious diseases, today announced that it has...